IDH2 and chondrosarcoma: This analysis seeks to aggregate data from all studies published to date with known IDH mutation status and oncologic outcomes, and isolate confounding variables to conduct a high-powered analysis of IDH status and its correlation to disease progression and survival in patients with chondrosarcoma.